Sterile Mycophenolate Mofetil for Injection Formulation from Japan
Sterile-grade mycophenolate mofetil powder intended for IV injection formulation after further processing. Classified under HTS 2934.99.01.00 as bulk aromatic heterocyclic API despite sterile processing, per Chapter 29 notes excluding only finished medicaments. Meets parenteral quality standards with endotoxin limits <0.5 EU/mg.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide bacterial endotoxin test results and sterility assurance documentation for parenteral use
• Nitrogen purged containers required to prevent oxidative degradation during ocean transit
• Particle size distribution data critical for injection formulation compatibility